Article
Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Journal of virology - 1 Jun 2015
Gromowski Gregory D, Firestone Cai-Yen, Whitehead Stephen S
Abstract excerpt
UNLABELLED: The safety and efficacy of the live-attenuated Japanese encephalitis virus (JEV) SA14-14-2 vaccine are attributed to mutations that accumulated in the viral genome during its derivation. However, little is known about the contribution that is made by most of these mutations to virulence attenuation and vaccine immunogenicity. Here, we generated recombinant JEV (rJEV) strains containing JEV SA14-14-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
